Vericel Corp Ord (VCEL)

Vericel Corp Ord (VCEL) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 26, 2026: market cap $2.1B; returns 1 day +1.2%, 1 week +6.6%, 1 year +18.5%.

Vericel Corporation is a commercial-stage biopharmaceutical company that develops and commercializes autologous cell therapies for the sports medicine and severe burn care markets. The company's business model is centered on using a patient's own cells to manufacture personalized treatments.

Groups VCEL belongs to

• Biotechnology
• Autologous Cell Therapy
• Commercial Stage
• Commercial Stage Biotech
• Personalized Medicine
• Regenerative Medicine
• Healthcare
• Life Sciences
• Biopharmaceutical
• Healthcare Services
• Orthopedics

VCEL financial model: income statement, cash flow and balance sheet